Eu Pharma Consultants Ltd
- Liquidation
- Micro
- 15 years
- Confirmation overdue 5 months
- 1 employee
- £236,584 (cur assets)
- 0-1m
- Virtual address
- 1 director
- 1 owner
- Manchester
Two conditions of three:
1.Turnover < £632,000
2.Balance sheet total < £316,000
3.Average number of employees < 10
Field of Operation
Summary
Eu Pharma Consultants Ltd is a private limited company registered in England/Wales with the registration number 07435112. The company was founded fifteen years ago on November 10, 2010, and registered at M2 4LQ, Manchester, Suite 2 The Offices, 53 King Street. The address is probably virtual as 207 companies are registered at the same address. Its status is liquidation. Please be careful, the status indicates serious problems in the company. The company operates in the professional services, the professional services n.e.c. industries. Officially, it has one owner or PSCs, one director, and one employee.
It's a micro company as it met two conditions of three: turnover less than £632,000, balance sheet total less than £316,000, employees less than 10. The last reported current assets is £236,584.
WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.
Owners & PSC
-
Individual
- 9 years
- 25%+
-
Resident of United Kingdom
Managers
-
Individual
- 15 years
- 1
-
Resident of United Kingdom
Last reports
The latest confirmation statement submitted one year ago.
Last news
-
Registered office address changed from C/O Clarke Bell Limited 3rd Floor the Pinnacle 73 King Street Manchester M2 4NG to Suite 2 the Offices 53 King Street Manchester M2 4LQ on 2026-06-17Download 3 pages pdf report
-
Appointment of a voluntary liquidatorDownload 2 pages pdf report
-
ResolutionsDownload 1 page pdf report
FAQ about Eu Pharma Consultants Ltd
Looking for leads in the UK?
Book a demo—see how CorpSignals can help you find UK leads.